Navigation Links
Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
Date:1/23/2010

ith non-ST-segment elevation acute coronary syndrome (NSTE-ACS). The randomized study with 60 patients compared the Genous Bio-engineered R stent with bare metal stents with concomitant high dose atorvastatin in the reduction of neointimal hyperplasia assessed by coronary angiography and IVUS after six months.

In the JACK-EPC trial, the Genous Bio-engineered R stent induced less neointimal hyperplasia and a lower binary restenosis rate of 13 percent in the Genous Bio-engineered R stent, compared to 26.6 percent in the control group. Importantly, the major adverse cardiac events (MACE) rate was reported at only 10 percent in the Genous Bio-engineered R stent treated patient group versus 16 percent in the bare metal stent treated group.

"In our small study, we observed a lower amount of neointimal proliferation with the EPC capture stent compared to the bare metal stent control," said Wojakowski.  "Good safety is indicated by comparable stent thrombosis.  We think this makes the Genous stent a very promising treatment strategy for ACS patients, especially those with high risk of bleeding or not eligible for prolonged dual antiplatelet therapy due to allergy to ASA or clopidogrel."

"Data from both presentations support the use of the Genous Bio-engineered R stent as an effective treatment option in what interventional cardiologists find to be challenging cases," said Al Novak, OrbusNeich's chairman and CEO. "We look forward to continuing to work with physicians to realize the full potential of the Genous technology."

About Genous  

Genous is OrbusNeich's patented endothelial progenitor cell (EPC) capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devices such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams Pre-Clinical Development of Neuroprotective Parkinsons Therapies
2. Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
3. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
4. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
5. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
6. Enbrel Will Remain Decision Resources Clinical Gold Standard Through 2018 for the Treatment of Rheumatoid Arthritis
7. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
8. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
9. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
10. New Clinical Study Finds Masimo Perfusion Index (PI) Predicts Low Systemic Blood Flow in Preterm Infants
11. DATATRAKs eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014 MC Medical, a ... (MID), a Columbus, OH medical device ... the FloShield laparoscopic and robotic visualization system in ... approved for sale in Japan in ... long-time experience and an extensive product portfolio in endoscopic surgery ...
(Date:8/22/2014)...  Mark Riccio, director of Cornell University,s multi-scale ... the online crowd-funding platform Kickstarter to bring non-invasive ... and would-be superheros everywhere: "for FREE." Riccio,s campaign, ... if you had Superman,s X-ray vision?" The campaign ... from elementary through high school students, academic institutions, ...
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... Musculoskeletal Transplant Foundation (MTF) has announced the release of two ... The new sizes--16cm x 20cm and 20cm x 20cm--are being ... their patients. This unique human dermal allograft is specifically prepared ... has been a year since MTF introduced its bi-lateral breast ...
... -- Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" or the ... and drugs in the People,s Republic of China ("PRC"), ... its Inner Mongolia branch company, including land use right ... Inner Mongolia, in order to focus its business on ...
Cached Medicine Technology:New, Larger, Bilateral Breast Graft Kits Announced by MTF 2Lotus Pharmaceuticals Announces Business Reorganization and Provides Updates on the Beijing Headquarters Building 2Lotus Pharmaceuticals Announces Business Reorganization and Provides Updates on the Beijing Headquarters Building 3
(Date:8/23/2014)... 2014 GBI Research, the leading business ... Therapeutics in Major Developed Markets to 2020 - New ... Market”, which provides in-depth analysis of the critical care ... Japan and Canada. The report provides an estimation of ... 2020. It covers critical care indications that are being ...
(Date:8/23/2014)... Pixel Film Studios, a leader of Final ... of ProIntro Vol.3, a customizable title tool for FCPX ... just by dragging ProIntro Vol.3 in their timeline" says Christina ... definite time saver and i think our users will agree" ... designed titles made with Final Cut Pro X users in ...
(Date:8/23/2014)... Houston, TX (PRWEB) August 23, 2014 ... state of Texas. It’s no different in Houston, TX. ... Juveniles are falling victim to drug and alcohol dependency ... people are looking to beat substance abuse, but don’t ... a juvenile treatment facility can be a challenge because ...
(Date:8/23/2014)... Summer vacation is almost over and before we know ... shopping for school supplies and a new wardrobe might take ... students to also spend some time brushing up on bed ... thrive in heavily populated places,” said Randy Rupert, Bed Bug ... perfect settings for bed bugs to take up residence.” , ...
(Date:8/22/2014)... 2014 Deep Research Report on Global ... research report on the Glucose Meter market. The ... Meter definition, classification, application, and industry chain structure ... the international market analysis, including domestic market as ... & economic situation analysis. The report on Glucose ...
Breaking Medicine News(10 mins):Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 2Health News:Critical Care Therapeutics in Major Developed Markets to 2020 | Researchmoz 3Health News:A new plugin was announced today, ProIntro Vol.3 from Pixel Film Studios for Final Cut Pro X 2Health News:New Houston Hotline Assisting Juveniles in Locating Dependable Rehabilitation Help 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3
... The "Get Your Head in the Game(R)" Awareness Walk held ... Brain Tumor Foundation (KHG), the only organization in the US ... tumors. (Photo: http://www.newscom.com/cgi-bin/prnh/20090505/PH11172 ... major sponsors also moves KHG ( www.khgfoundation.com ) ...
... System Warns that Snake Bites are Becoming More Powerful and ... in weather marks a change in rattlesnake behavior as well. ... not poisonous, the rattlesnake is. In humans, a rattlesnake ... fatal. "Over the past couple of years we have seen ...
... HARBOR, N.Y. (May 5, 2009) The ... provide a supportive yet flexible framework that allows vertebrates ... knowledge about the vertebrate skeleton, especially recent research on ... a new monograph, The Skeletal System . ...
... /PRNewswire/ - Medical device company, Intelligent Hospital ... agreement with the South Korean pharmacy application ... Seoul. Daeiltech will provide direct sales and ... (Robotic IV Automation) across South Korea. , ...
... VIEW, Calif., May 5 As early diagnosis ... survival, and better quality of life for patients, ... for primary care. Innovative molecular technologies have generated ... new market entrants. These efforts will go a ...
... Serve as Honorary Co-chair of EventBALTIMORE, May 5 The ... Reeves, former lead singer of the Motown group Martha and ... for the organization,s fundraising walk-a-thon event. The third annual ... will take place on the morning of July 6, 2009, ...
Cached Medicine News:Health News:Walk Raises Almost $200,000 to Heighten Brain Tumor Awareness 2Health News:As the Weather Warms Up Rattlesnakes Come Out to Enjoy the Sun Just as Californians Do 2Health News:New book summarizes current knowledge on the biology of the vertebrate skeleton 2Health News:IH Systems Extends Global Reach into South Korean Medical Device Market 2Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 2Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 3Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 4Health News:Martha Reeves to Participate in the National Federation of the Blind Motor City March for Independence 2
... Neuro-Patch is a non-absorbable ... highly purified polyesterurethane. Its ... proliferation of fibroblast, supporting ... "weave" minimizes suture channels, ...
The Bovie IDS Series are the latest electrosurgical generators with fully digital implementation....
Aaron 2250 is a multipurpose electrosurgical generator with monoploar and bi-polar functions....
Adson bipolar forceps, 12 cm, straight....
Medicine Products: